Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, September 17, 2015
AbbVie in cooperation with Neurocrine Biosciences, Inc. has announced the completion of a Phase 2b clinical trial evaluating the safety and efficacy of elagolix alone or in combination with add-back therapy compared to placebo
read more
Thursday, January 03, 2013
AbbVie today marks its launch as an independent biopharmaceutical company, with employees from more than 40 countries and patients joining AbbVie leaders as they ring the first opening bell of 2013 at the New York Stock Exchange.
read more
Abbvie has completed its $21B buyout of Pharmacyclics.
read more
Abbvie has released details of the stock and cash breakdown of its previously announced $21B buyout of Pharmacyclics.
read more
AbbVie and Capstan Therapeutics announced a definitive agreement under which AbbVie will acquire Capstan, including CPTX2309, a potential first-in-class in vivo tLNP anti-CD19 CAR-T therapy candidate, currently in Phase 1, in development for the ...
read more
AbbVie and Calibr announced a collaboration to develop T-cell therapies aimed primarily at cancer, including solid tumors.
read more
AbbVie, Genomics Medicine Ireland Limited, and WuXi NextCODE have announced the launch of a long-term strategic alliance to conduct population genomics research in Ireland aimed at advancing the discovery and development of novel therapeutic ...
read more
Monday, December 16, 2019
AbbVie and Scripps Research announced a collaboration to develop new therapies for a range of diseases, including in the therapeutic areas of oncology, immunology, neurology and fibrosis.
read more
Thursday, October 31, 2013
“The launch of the new brand logo is an outward sign of an important transformation that’s been ongoing for the past couple of years,” said John D. Bucksath, President and CEO. “The entire organization has worked very hard to get where we are today. ...
read more
Abcam has announced the acquisition of Expedeon's Proteomics and Immunology business, which includes Innova and TGR Biosciences, as of 1st January 2020.
read more
Building on exisiting three-year collaboration, Abcam and MEDx extend their strategic partnership, focusing on co-development of in vitro diagnostic kits to support demand in China.
read more
Tuesday, January 29, 2019
Abcam has announced its acquisition of Calico Biolabs, a developer of custom recombinant rabbit monoclonal antibodies for diagnostics and pharmaceutical company partners.
read more
Thursday, September 22, 2022
AbCellera launched the second phase of its global headquarters expansion by breaking ground on its new facility in Vancouver, Canada.
read more
AbCellera announced a two-year agreement with the Bill & Melinda Gates Foundation to help accelerate global health research.
read more
Abdi Ibrahim has selected rfxcel to implement and support new compliance management and serialization processing software.
read more